Mark Bennett
AbbVie (United Kingdom)(GB)
Publications by Year
Research Areas
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Child and Adolescent Psychosocial and Emotional Development, Epilepsy research and treatment, Olfactory and Sensory Function Studies, Treatment of Major Depression
Most-Cited Works
- → A strategic view on smart city technology: The case of IBM Smarter Cities during a recession(2013)280 cited
- → A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania(2010)148 cited
- → Topiramate augmentation in treatment-resistant obsessive–compulsive disorder: a retrospective, open-label case series(2005)122 cited
- → An Open Trial of Topiramate in the Treatment of Generalized Social Phobia(2004)80 cited
- → Antiepileptic Drugs in the Treatment of Anxiety Disorders(2004)80 cited
- → Emerging Treatments for Child and Adolescent Social Phobia: AReview(2005)61 cited
- → Optimizing Treatment in Social Phobia: A Review of Treatment Resistance(2004)46 cited
- → The Prevalence of Migraine Headaches in an Anxiety Disorders Clinic Sample(2010)40 cited
- → Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series(2007)34 cited
- → Nefazodone in the Treatment of Generalized Social Phobia(2007)30 cited